Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea
· Delayed Price · Currency is KRW
3,235.00
+5.00 (0.15%)
At close: Mar 24, 2025, 3:30 PM KST
Hyundai Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is December - November.
Millions KRW. Fiscal year is Dec - Nov.
Current | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
Mar '25 Mar 31, 2025 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Market Capitalization | 85,247 | 42,443 | 36,229 | 27,905 | 38,340 | 55,972 | |
Market Cap Growth | 17.15% | 17.15% | 29.83% | -27.22% | -31.50% | -0.39% | |
Enterprise Value | 48,445 | 48,445 | 43,620 | 36,761 | 49,208 | 69,151 | |
Last Close Price | 3080.00 | 1585.87 | 1322.16 | 994.81 | 1321.64 | 1793.06 | |
PE Ratio | 51.05 | 30.00 | - | 53.65 | 12.92 | 33.50 | |
PS Ratio | 0.67 | 0.39 | 0.35 | 0.24 | 0.34 | 0.46 | |
PB Ratio | 0.72 | 0.42 | 0.36 | 0.27 | 0.41 | 0.60 | |
P/TBV Ratio | 0.43 | 0.43 | 0.37 | 0.28 | 0.42 | 0.61 | |
P/FCF Ratio | 14.93 | 7.43 | - | 10.79 | - | - | |
P/OCF Ratio | 5.34 | 5.34 | - | 4.45 | 14.32 | - | |
EV/Sales Ratio | 0.45 | 0.45 | 0.43 | 0.32 | 0.44 | 0.56 | |
EV/EBITDA Ratio | 11.27 | 11.27 | - | 6.20 | 35.00 | 18.32 | |
EV/EBIT Ratio | 22.15 | 22.15 | - | 10.62 | - | 59.08 | |
EV/FCF Ratio | 8.49 | 8.49 | - | 14.22 | - | - | |
Debt / Equity Ratio | 0.21 | 0.21 | 0.29 | 0.27 | 0.24 | 0.25 | |
Debt / EBITDA Ratio | 4.83 | 4.83 | - | 4.69 | 15.65 | 6.23 | |
Debt / FCF Ratio | 3.63 | 3.63 | - | 10.76 | - | - | |
Asset Turnover | 0.74 | 0.74 | 0.67 | 0.79 | 0.84 | 0.93 | |
Inventory Turnover | 3.00 | 3.00 | 3.07 | 4.41 | 4.42 | 4.89 | |
Quick Ratio | 1.62 | 1.62 | 1.41 | 1.55 | 1.80 | 1.64 | |
Current Ratio | 2.20 | 2.20 | 1.97 | 1.94 | 2.21 | 2.07 | |
Return on Equity (ROE) | 1.45% | 1.45% | -4.75% | 0.55% | 3.21% | 1.80% | |
Return on Assets (ROA) | 0.93% | 0.93% | -1.76% | 1.50% | -0.42% | 0.55% | |
Return on Capital (ROIC) | 1.09% | 1.09% | -2.07% | 1.75% | -0.48% | 0.64% | |
Return on Capital Employed (ROCE) | 2.00% | 2.00% | - | 3.10% | - | 1.20% | |
Earnings Yield | 1.66% | 3.33% | -13.39% | 1.86% | 7.74% | 2.99% | |
FCF Yield | 6.70% | 13.45% | -11.47% | 9.27% | -3.31% | -16.46% | |
Dividend Yield | 0.93% | 2.65% | - | - | 3.40% | 2.79% | |
Payout Ratio | 62.32% | 62.32% | - | 202.97% | 41.25% | 95.71% | |
Buyback Yield / Dilution | -0.08% | -0.08% | 0.90% | 0.97% | 2.94% | 7.44% | |
Total Shareholder Return | 0.84% | 2.56% | 0.90% | 0.97% | 6.34% | 10.23% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.